Adamas Pharmaceuticals, Inc.
Adamas is a pharmaceutical company committed to developing and commercializing products and product candidates for the treatment of chronic neurological disorders.
Last Closing Price
January 24, 2018
BofA Merrill Lynch, Leerink, Evercore ISI
To view the prospectus for Adamas Pharmaceuticals, Inc., or any offering listed on ClickIPO,
download the ClickIPO app...
or a prospectus can be requested from G. Price at
ClickIPO Securities, LLC P. O. Box 21154, Mesa, AZ 85277